Clinical Trial Update: Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating palonosetron plus dexamethasone to prevent chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy; sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Neoplasms

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Palonosetron (palonosetron)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Nausea | Phase 4 | Status: COMPLETED